Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Predictive Oncology — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Predictive Oncology Partners with Tecan Group Ltd. for High-Throughput Drug Screening Expansion

Feb 10, 2025•over 1 year ago

Contract Type

partnership

PittsburghInformation TechnologyBiotechnologyHealthcareArtificial IntelligenceBlockchainCryptocurrency

Description

Predictive Oncology Inc. announced a partnership with Switzerland-based Tecan, Ltd. to expand high-throughput drug screening to include human tumor spheroids using automated imaging and 3D analysis. This collaboration aims to utilize Predictive Oncology’s vast biobank of cryopreserved live cell tumor specimens for the production and testing of primary patient tumor spheroids.

Company Information

Company

Predictive Oncology

Location

Pittsburgh, Pennsylvania, United States

About

Predictive Oncology is on a mission to transform oncology drug discovery and drive the development of more effective cancer therapies. By leveraging machine learning, scientific expertise, and biologics, we work to increase the probability of success and advance drug compounds with greater precision and confidence.

Predictive Intelligence
Strategic

ML-powered predictions for Predictive Oncology's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Sign in to view contact details

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months